Angiodynamics to report fiscal 2026 first quarter results on october 2, 2025

Latham, n.y.--(business wire)--angiodynamics, inc. (nasdaq: ango), a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving patient quality of life, today announced that it will report financial results for the first quarter of fiscal year 2026 before the market open on thursday, october 2, 2025. the company's management will host a conference call at 8:00 am et the same day to.
ANGO Ratings Summary
ANGO Quant Ranking